• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.52% Nasdaq Up 0.26%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    95.97 Down 12.48(11.51%) 1:58PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:108.45
    Open:96.60
    Bid:95.90 x 500
    Ask:95.92 x 100
    1y Target Est:126.17
    Beta:1.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:92.45 - 104.30
    52wk Range:63.50 - 116.83
    Volume:51,581,221
    Avg Vol (3m):14,994,200
    Market Cap:144.79B
    P/E (ttm):17.10
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 11.51%144.79B
    GSKUp 0.48%104.71B
    PFEDown 0.06%201.12B
    RHHBYUp 0.84%236.19B

    Key Statistics

    Forward P/E (1 yr):9.52
    P/S (ttm):7.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.94
    Quarterly EPS Est (Dec-14) :2.27
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback